3-(2,5-DICHLOROPYRIDIN-4-YL)-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDINE

Catalog No. :
ACNEHF866
CAS No. :
2057506-08-6
Molecular Formula :
C12H11Cl2N3
Molecular Weight :
268.15

IUPAC Name:3-(2,5-dichloropyridin-4-yl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine

3-(2,5-DICHLOROPYRIDIN-4-YL)-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDINE structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$511.00Login to see priceInquiryInquiry
1g95%$1279.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(2,5-DICHLOROPYRIDIN-4-YL)-5,6,7,8-TETRAHYDROIMIDAZO[1,2-A]PYRIDINE
IUPAC Name3-(2,5-dichloropyridin-4-yl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine
MDL No.MFCD31555493
Molecular FormulaC12H11Cl2N3
Molecular Weight268.15
SMILESClC1=CN=C(C=C1C2=CN=C3CCCCN32)Cl
InChI KeyUDRMFKFIJNFSNQ-UHFFFAOYSA-N
SynonymCID 124155148;Imidazo[1,2-a]pyridine, 3-(2,5-dichloro-4-pyridinyl)-5,6,7,8-tetrahydro-
CAS No.2057506-08-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNEHF866 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGOSX054 route compound structure diagram
    ACGOSX054156817-72-0 In Stock
  2. Plus
  3. ACNSAC230 route compound structure diagram
    ACNSAC230847664-64-6 In Stock
  4. Then
  5. ACNEHF866 route product structure diagram
    ACNEHF8662057506-08-6
Inquiry

2. ACNEHF866 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNSAC230 route compound structure diagram
    ACNSAC230847664-64-6 In Stock
  4. Then
  5. ACNEHF866 route product structure diagram
    ACNEHF8662057506-08-6
Inquiry

Comments (0)